- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 285/12 - 1,3,4-ThiadiazolesHydrogenated 1,3,4-thiadiazoles
Patent holdings for IPC class C07D 285/12
Total number of patents in this class: 172
10-year publication summary
|
16
|
17
|
10
|
5
|
4
|
6
|
7
|
1
|
8
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4751 |
6 |
| Oryzon Genomics S.A. | 103 |
5 |
| Reata Pharmaceuticals, Inc. | 108 |
5 |
| Receptos LLC | 59 |
5 |
| The Lubrizol Corporation | 1265 |
4 |
| Omeros Corporation | 307 |
4 |
| Merck Sharp & Dohme LLC | 3734 |
4 |
| Glaxo Group Limited | 4361 |
3 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2326 |
3 |
| KYORIN Pharmaceutical Co., Ltd. | 152 |
3 |
| Ohio State Innovation Foundation | 2442 |
3 |
| Piramal Enterprises Limited | 151 |
3 |
| Proteostasis Therapeutics, Inc. | 67 |
3 |
| PTC Therapeutics, Inc. | 462 |
3 |
| Taisho Pharmaceutical Co., Ltd. | 850 |
3 |
| Toyama Chemical Co., Ltd. | 87 |
3 |
| BASF SE | 21334 |
2 |
| FUJIFILM Corporation | 30849 |
2 |
| Board of Regents, The University of Texas System | 6206 |
2 |
| Takeda Pharmaceutical Company Limited | 2708 |
2 |
| Other owners | 104 |